Sumatriptan Succinate
Product Images NDC 66116-413

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 66116-413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Sumatriptan Succinate (2fbc01fb B787 4ff1 Bb9f 280dfe975531 01)

Chemical structure of sumatriptan succinate, showing the molecular arrangement of the active ingredient, including sulfonamide, indole, and dimethylamine groups with succinate counterions.*

FDA Label Image

Figure 1: Estimated Probability Of Achieving Initial Headache Response Within 240 Minutes* (2fbc01fb B787 4ff1 Bb9f 280dfe975531 02)

A line graph showing the estimated probability of response over a 240-minute period after the initial dose of Sumatriptan Succinate. The graph compares placebo with three dosage levels: 25 mg, 50 mg, and 100 mg, illustrating increased response probability with higher doses over time.*

FDA Label Image

Figure 2: The Estimated Probability Of Patients Taking A Second Dose Or Other Medication For Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment* (2fbc01fb B787 4ff1 Bb9f 280dfe975531 03)

A line graph showing the estimated probability of remedication or rescue over 24 hours from the initial dose for placebo and sumatriptan succinate at 25 mg, 50 mg, and 100 mg doses. The x-axis represents time in hours and the y-axis shows the probability percentage.*

FDA Label Image

Sumatriptan Succinate Tablets 50mg (2fbc01fb B787 4ff1 Bb9f 280dfe975531 04)

Label for Sumatriptan Succinate Tablets, 50 mg, containing 9 tablets. The label includes dosing instructions to see package insert and storage information to keep at controlled room temperature (20°-25°C). The product is labeled Rx Only and marked as Sample Only, Not for Sale. Manufactured by Teva Pharmaceutical Industries Ltd., Jerusalem, Israel, and distributed by MedVantx, Inc., San Diego, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.